arrow
A

Anil K. Pillai

university of texas system
H指数:23
被引数:1,897

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

ACR Appropriateness Criteria® Pulmonary Arteriovenous Malformation (PAVM): 2023 Update
2024-06-011
PRE
The phosphatidylserine targeting antibody bavituximab plus pembrolizumab in unresectable hepatocellular carcinoma: a phase 2 trial
2024-03-113
OAAI
The chromatin landscape of healthy and injured cell types in the human kidney

人类肾脏中健康和受损细胞类型的染色质景观

2024-01-108
OAAI
ACR Appropriateness Criteria® Lower Extremity Arterial Claudication-Imaging Assessment for Revascularization: 2022 Update
2022-11-013
OAAI
Postmortem study of organ-specific toxicity in glioblastoma patients treated with a combination of temozolomide, irinotecan and bevacizumab

替莫唑胺,伊立替康和贝伐单抗联合治疗的胶质母细胞瘤患者器官特异性毒性的死后研究

2022-10-063
PRE
ACR Appropriateness Criteria® Noncerebral Vasculitis
2021-11-019
OAAI